LRRK2

  • Inhibitory Selectivity
  • Solubility
Catalog No. Product Name Solubility(25°C)
Water DMSO Alcohol
S7343 URMC-099 <1 mg/mL 84 mg/mL 6 mg/mL
S7368 GNE-9605 <1 mg/mL 89 mg/mL 12 mg/mL
S7367 GNE-0877 <1 mg/mL 67 mg/mL <1 mg/mL
S7584 LRRK2-IN-1 <1 mg/mL 100 mg/mL 100 mg/mL
S7528 GNE-7915 <1 mg/mL 22 mg/mL <1 mg/mL
S7664 GSK2578215A <1 mg/mL 79 mg/mL <1 mg/mL
Catalog No. Information Product Use Citations Product Validations
S7343

URMC-099

URMC-099 is an orally bioavailable, brain penetrant mixed lineage kinase (MLK) inhibitor with IC50 of 19 nM, 42 nM, 14 nM, and 150 nM, for MLK1, MLK2, MLK3, and DLK, respectively, and also inhibits LRRK2 activity with IC50 of 11 nM.

S7368

GNE-9605

GNE-9605 is a highly potent and selective leucine-rich repeat kinase 2 (LRRK2) inhibitor with Ki and IC50 of 2 nM and 19 nM, respectively.

S7367

GNE-0877

GNE-0877 is a highly potent and selective leucine-rich repeat kinase 2 (LRRK2) inhibitor with Ki of 0.7 nM.
S7584

LRRK2-IN-1

LRRK2-IN-1 is a potent and selective LRRK2 inhibitor with IC50 of 6 nM and 13 nM for LRRK2 (G2019S) and LRRK2 (WT), respectively.

S7528

GNE-7915

GNE-7915 is a highly potent, selective, and brain-penetrable leucine-rich repeat kinase 2 (LRRK2) inhibitor, with IC50 and Ki of 9 nM and 1 nM, respectively.

S7664

GSK2578215A

GSK2578215A is a potent and selective LRRK2 kinase inhibitor with IC50 of 8.9 nM and 10.9 nM for LRRK2 (G2019S) and LRRK2 (WT), respectively.